Related references
Note: Only part of the references are listed.Brain metabolic dysfunction at the core of Alzheimer's disease
Suzanne M. de la Monte et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Within-patient correspondence of amyloid-β and intrinsic network connectivity in Alzheimer's disease
Nicholas Myers et al.
BRAIN (2014)
Type 3 diabetes is sporadic Alzheimer's disease: Mini-review
Suzanne M. de la Monte
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Intracerebroventricular Streptozotocin Exacerbates Alzheimer-Like Changes of 3xTg-AD Mice
Yanxing Chen et al.
MOLECULAR NEUROBIOLOGY (2014)
Glial activation and post-synaptic neurotoxicity: The key events in Streptozotocin (ICV) induced memory impairment in rats
Shivika Rai et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease
Chaoyun Li et al.
AGEING RESEARCH REVIEWS (2013)
Mitochondrial Abnormalities in a Streptozotocin-Induced Rat Model of Sporadic Alzheimer's Disease
Sonia C. Correia et al.
Current Alzheimer Research (2013)
Gliotransmission and Brain Glucose Sensing Critical Role of Endozepines
Damien Lanfray et al.
DIABETES (2013)
Palmitate induces transcriptional regulation of BACE1 and presenilin by STAT3 in neurons mediated by astrocytes
Li Liu et al.
EXPERIMENTAL NEUROLOGY (2013)
What causes Alzheimer's disease?
Richard A. Armstrong
FOLIA NEUROPATHOLOGICA (2013)
Hepatic glucose sensing is required to preserve β cell glucose competence
Pascal Seyer et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The role of amyloid β in the pathogenesis of Alzheimer's disease
Barnabas James Gilbert
JOURNAL OF CLINICAL PATHOLOGY (2013)
Tanycyte-like cells form a blood-cerebrospinal fluid barrier in the circumventricular organs of the mouse brain
Fanny Langlet et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2013)
What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research
Melita Salkovic-Petrisic et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
A Non-transgenic Mouse Model (icv-STZ Mouse) of Alzheimer's Disease: Similarities to and Differences from the Transgenic Model (3xTg-AD Mouse)
Yanxing Chen et al.
MOLECULAR NEUROBIOLOGY (2013)
Alzheimer's Disease Pathologic Cascades: Who Comes First, What Drives What
Russell H. Swerdlow
NEUROTOXICITY RESEARCH (2012)
Early and late neurodegeneration and memory disruption after intracerebroventricular streptozotocin
Taisa de Oliveira Santos et al.
PHYSIOLOGY & BEHAVIOR (2012)
In Vivo Cross-sectional Characterization of Cerebral Alterations Induced by Intracerebroventricular Administration of Streptozotocin
Audrey Kraska et al.
PLOS ONE (2012)
Insulin in the brain: There and back again
William A. Banks et al.
PHARMACOLOGY & THERAPEUTICS (2012)
A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β
Jeffrey J. Iliff et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease?
Sonia C. Correia et al.
AGEING RESEARCH REVIEWS (2011)
ICV STZ induced impairment in memory and neuronal mitochondrial function: A protective role of nicotinic receptor
Gunjan Saxena et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Brain glucose sensing and neural regulation of insulin and glucagon secretion
B. Thorens
DIABETES OBESITY & METABOLISM (2011)
Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study
Melita Salkovic-Petrisic et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies
Diana W. Shineman et al.
ALZHEIMERS RESEARCH & THERAPY (2011)
Glial glucokinase expression in adult and post-natal development of the hypothalamic region
Carola Millan et al.
ASN NEURO (2010)
APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis
Leslie Crews et al.
BRAIN STRUCTURE & FUNCTION (2010)
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
N. C. Turner et al.
BRITISH JOURNAL OF CANCER (2010)
Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis
Siddhartha Mondragon-Rodriguez et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Is Insulin Resistant Brain State a Central Feature of the Metabolic-Cognitive Syndrome?
Vincenza Frisardi et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition
Andrei G. Vlassenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
'Too much good news' - are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease?
Kathleen R. Zahs et al.
TRENDS IN NEUROSCIENCES (2010)
BRAIN GLUCOSE TRANSPORTER PROTEIN 2 AND SPORADIC ALZHEIMER'S DISEASE
Melita Salkovic-Petrisic et al.
TRANSLATIONAL NEUROSCIENCE (2010)
Dysregulation of Insulin Signaling, Glucose Transporters, O-GlcNAcylation, and Phosphorylation of Tau and Neurofilaments in the Brain Implication for Alzheimer's Disease
Yanqiu Deng et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Of Mice and Men Bridging the Translational Disconnect in CNS Drug Discovery
Hugo Geerts
CNS DRUGS (2009)
Modeling Sporadic Alzheimer's Disease: The Insulin Resistant Brain State Generates Multiple Long-Term Morphobiological Abnormalities Including Hyperphosphorylated Tau Protein and Amyloid-beta
Melita Salkovic-Petrisic et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats
Vinod Tiwari et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Intracerebroventricular Administration of Drugs
Aaron M. Cook et al.
PHARMACOTHERAPY (2009)
Free fatty acids and skeletal muscle insulin resistance
Edward W. Kraegen et al.
CURRENT OPINION IN LIPIDOLOGY (2008)
Hippocampal hypornetabolism predicts cognitive decline from normal aging
Lisa Mosconi et al.
NEUROBIOLOGY OF AGING (2008)
Antioxidant capacity in rat brain after ICV treatment with streptozotocin and alloxan - a preliminary study
A. Sapcanin et al.
NEUROTOXICITY RESEARCH (2008)
The mechanisms of alloxan- and streptozotocin-induced diabetes
S. Lenzen
DIABETOLOGIA (2008)
Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons
Sachin Patil et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein
Edna Gruenblatt et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Reduced hippocampal neurogenesis and number of hilar neurones in streptozotocin-induced diabetic mice: reversion by antidepressant treatment
J Beauquis et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway
M Salkovic-Petrisic et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Energy inhibition elevates β-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice:: Possible early events in Alzheimer's disease pathogenesis
RA Velliquette et al.
JOURNAL OF NEUROSCIENCE (2005)
Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening
K Srinivasan et al.
PHARMACOLOGICAL RESEARCH (2005)
The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse
R Schechter et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Diabetes mellitus concomitantly facilitates the induction of long-term depression and inhibits that of long-term potentiation in hippocampus
A Artola et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Shock, inflammation and PARP
S Cuzzocrea
PHARMACOLOGICAL RESEARCH (2005)
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes?
E Steen et al.
JOURNAL OF ALZHEIMERS DISEASE (2005)
Role for neuronal insulin resistance in neurodegenerative diseases
M Schubert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Distribution and anatomical localization of the glucose transporter 2 (GLUT2) in the adult rat brain - an immunohistochemical study
M Arluison et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2004)
Third ventricular alloxan reversibly impairs glucose counterregulatory responses
NM Sanders et al.
DIABETES (2004)
Hyperglycemia-induced oxidative stress in diabetic complications
GL King et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2004)
Hypothalamic ependymal-glial cells express the glucose transporter GLUT2, a protein involved in glucose sensing
MD García et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats
S Shoham et al.
EXPERIMENTAL NEUROLOGY (2003)
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
TP Degenhardt et al.
KIDNEY INTERNATIONAL (2002)
Fatty acid uptake and incorporation in brain -: Studies with the perfusion model
QR Smith et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2001)
Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs
KJ Kaiyala et al.
DIABETES (2000)
Share Paper
